Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,948 | 17,946 | 28,372 | 62,780 | 27,062 |
| Marketable Securities | 98,783 | 122,311 | 140,739 | 130,762 | 208,981 |
| Receivables | 2,410 | 4,050 | 3,078 | 3,595 | 3,681 |
| Inventories | 775 | 878 | 874 | 1,059 | 1,126 |
| TOTAL | $118,640 | $151,342 | $176,776 | $202,731 | $243,736 |
| Non-Current Assets | |||||
| PPE Net | 11,153 | 11,652 | 11,098 | 10,942 | 10,648 |
| Intangibles | 14,400 | 14,734 | 12,409 | 14,084 | 15,760 |
| Other Non-Current Assets | 7,480 | 9,052 | 12,847 | 13,524 | 11,853 |
| TOTAL | $33,033 | $35,438 | $36,354 | $38,550 | $38,261 |
| Total Assets | $151,673 | $186,780 | $213,130 | $241,281 | $281,997 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,265 | 2,250 | 1,657 | 1,576 | 1,331 |
| Accounts payable and accrued liabilities | 974 | 2,444 | 975 | 1,153 | 596 |
| Accrued Expenses | 13,158 | 15,796 | 18,172 | 12,624 | 15,113 |
| TOTAL | $17,400 | $21,493 | $21,327 | $15,876 | $17,563 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,082 | 4,614 | 3,046 | 3,305 | 1,381 |
| Deferred Revenues | 1,003 | 1,003 | 523 | 523 | 523 |
| Other Non-Current Liabilities | 115,100 | 115,100 | 175,000 | 175,000 | 175,000 |
| TOTAL | $121,021 | $121,804 | $180,019 | $180,413 | $178,621 |
| Total Liabilities | $138,421 | $143,297 | $201,346 | $196,289 | $196,184 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3 | 3 | 3 | 3 | 3 |
| Common Shares | 385,284 | 384,994 | 384,044 | 385,993 | 400,095 |
| Retained earnings | -370,924 | -340,455 | -370,992 | -340,600 | -314,112 |
| Other shareholders' equity | -1,108 | -1,056 | -1,268 | -401 | -170 |
| TOTAL | $13,252 | $43,483 | $11,784 | $44,992 | $85,813 |
| Total Liabilities And Equity | $151,673 | $186,780 | $213,130 | $241,281 | $281,997 |